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Inhibition of Angiotensin-Converting
Enzyme Reduces Cerebral Infarction Size
in Experimental-Induced Focal Cerebral
Ischemia in the Rat
Abstract
Background: The role of Renin Angiotensin System (RAS) in
ischemic/reperfusion (I/R) injuries is not fully elucidated. Fur-
thermore, it is not clear whether inhibition of RAS by Angio-
tensin-Converting Enzyme (ACE) inhibitors has beneficial
effects in terms of protecting the brain from I/R injuries. In
this study enalapril is used as an ACE inhibitor to evaluate the
role of RAS in I/R injuries in the rat.
Methods: ACE inhibition was performed one hour before induc-
tion of ischemia using a single IP injection of 0.03 mg/kg or 0.1
mg/kg enalapril in the rats. Transient focal cerebral ischemia was
induced by 60 min occlusion of the middle cerebral artery fol-
lowed by reperfusion. Neurological deficit score (NDS) test was
performed 24 hours after the start of reperfusion. Finally the ani-
mals were sacrificed under deep anesthesia, the brain removed
and prepared for the evaluation of cortical and striatal infarction
volumes using Triphenyltetrazolium chloride staining method.
Results: Pre-ischemic inhibition of ACE with non-hypotensive
dose of enalapril (0.03mg/kg) significantly reduced cortical and
striatal infarction volumes of ischemic rats by 41.6% and 52.7%
respectively with concomitant improvements in NDS. How-
ever, no improvement was observed when ACE inhibition ac-
companied with arterial hypotension.
Conclusion: In the rat model of transient focal cerebral ischemia,
ACE inhibition seems to reduce the severity of I/R injuries.
Therefore, it is plausible to conclude that renin-angiotensin-
system may participate in ischemic/reperfusion injuries.
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Introduction
arious therapeutic strategies have been developed to
attenuate the stroke-induced neuronal injury and the
subsequent neurologic deficits and disability.
1
Recent
experimental and clinical studies have suggested that inhibition of
the renin-angiotensin system (RAS) by Angiotensin Converting
Enzyme (ACE) inhibitors or Angiotensin II type 1 (AT1) receptor
antagonists may be effective in reducing the incidence of
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